
Neghae Mawla MD FASDIN
Interventional Nephrology
Dallas Nephrology Associates
Join to View Full Profile
4401 Tradition TrlPlano, TX 75093
Phone+1 214-358-2300
Fax+1 214-579-6941
Dr. Mawla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- SSM Health/Saint Louis University School of MedicineFellowship, Nephrology, 2004 - 2006
- SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2001 - 2004
- McGovern Medical School at UTHealthClass of 2001
Certifications & Licensure
- CA State Medical License 2025 - 2027
- NC State Medical License 2025 - 2025
- TX State Medical License 2006 - 2025
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Fellow ASDIN American Society of Diagnostic and Interventional Nephrology, 2018
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD Start of enrollment: 2015 Feb 10
Publications & Presentations
PubMed
- 7 citationsLong-Term Results from the Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access.Jeffrey E Hull, William C Jennings, Randy I Cooper, Rajeev Narayan, Neghae Mawla
Journal of Vascular and Interventional Radiology. 2022-10-01 - 20 citationsFormation of downhill esophageal varices as a rare but serious complication of hemodialysis access: a case report and comprehensive literature review.Fadi A. Hussein, Neghae Mawla, Alex S. Befeler, Kevin J. Martin, Krista L. Lentine
Clinical and Experimental Nephrology. 2008-04-10
Press Mentions
- Venova Medical Receives FDA IDE Approval for the VENOS-3 Pivotal Study of the Velocity™ Percutaneous AVF SystemAugust 21st, 2025
- Venova’s Velocity pAVF System Pivotal Study Receives IDE ApprovalAugust 21st, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: